The National Center for Regenerative Medicine and Case Comprehensive Cancer Center announce the appointment of Timothy Chan, MD, PhD, cancer biology and immunogenomics expert, as co-director of the National Center for Regenerative Medicine.
Dr. Chan is also Chair and Founding Director of the Center for Immunotherapy and Precision Immuno-Oncology at Cleveland Clinic, which focuses on immunotherapy research and developmental therapeutics. The new center will include a Cleveland cell therapy program in collaboration with the Case Comprehensive Cancer Center. Dr. Chan is also on staff in the Genomic Medicine Institute of the Lerner Research Institute and the Department of Radiation Oncology of the Taussig Cancer Institute.
Prior to arriving in Cleveland, Dr. Chan was at Memorial Sloan Kettering for over a decade where he was the Paine Webber Chair in Cancer Genetics, Director of the Immunogenomics Program, and Vice Chair of the Department of Radiation Oncology. Dr. Chan is a National Cancer Institute Outstanding Investigator and an elected member of the American Association of Physicians (AAP). He has over 200 publications in journals including Nature, Science, The New England Journal of Medicine, Cell, and others. He is on the scientific advisory board for Cell and the Frederick National Laboratory/National Cancer Institute. He received an MD, a PhD in cancer genetics, completed a residency in radiation oncology, and a fellowship at the Johns Hopkins School of Medicine.
Dr. Chan is an exceptional addition to the National Center for Regenerative Medicine leadership team. You will be hearing much more from him in the coming months.
Stan Gerson, MD
Director, National Center for Regenerative Medicine